Viewing Study NCT06232330



Ignite Creation Date: 2024-05-06 @ 8:03 PM
Last Modification Date: 2024-10-26 @ 3:19 PM
Study NCT ID: NCT06232330
Status: COMPLETED
Last Update Posted: 2024-06-13
First Post: 2023-12-26

Brief Title: Effects of TOA Versus PNF Techniques on Trunk Control in Children With Hemiplegic Cerebral Palsy
Sponsor: Riphah International University
Organization: Riphah International University

Study Overview

Official Title: Effects of Task Oriented Approach Versus Rhythmic Initiation And Stabilization Techniques of PNF on Trunk Control in Children With Hemiplegic Cerebral Palsy
Status: COMPLETED
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Cerebral palsy occurs in 2-25 per 1000 live births seems to be the most common cause of lifelong physical disability and has an impact on the child caregivers and society The incidence of cerebral palsy continues to rise owing to the large numbers of premature and high-risk infants who survive Task-oriented arm approaches promote intensive meaningful and goal-oriented training in subjects and the voluntary functional activities of these subjects possibly reduce their motor disabilities
Detailed Description: The study will be randomized clinical trial used to evaluate the effectiveness of TOA and PNF on trunk control in children with hemiplegic cerebral palsy Subjects with hemiplegic cerebral palsy meeting the inclusion and exclusion criteria will be divided into two groups using non- probability sampling techniques Assessment will be done using trunk control measuring scale and pediatric reach test Group A will receive TOA and conventional therapy and Group B will receive PNF and conventional therapy

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None